December 2021
SirVir to present at the Biotech showcase in San Francisco (January 10-12 , 2021)
March 2021
Aposense and Bioasis Technologies Inc. Enter into a Research Collaboration
February 2021
SirVir Ltd., an Aposense subsidiary in the field of respiratory viral infections announce the fulfillment of a $14M milestone investment
June 2020
Aposense enters into an out-licensing agreement with Processa Pharmaceuticals
April 2020
SirVir obtained positive results in pre-clinical experiment against COVID-19
January 2020
Prof. Roger Kornberg mentions SirVir’s breakthrough results and applicability of the platform in an interview for Ynet